How to get Wellbutrin fast in Florida

If you’re struggling with binge eating disorder (BED) and wondering whether you can access treatment online, you’re not alone. Telehealth has transformed mental health care—but navigating the rules around prescribing medications remotely can feel overwhelming. The good news? Yes, you can receive evidence-based medication for binge eating disorder through telehealth in every U.S. state, and the process is often simpler than you might think.

This comprehensive guide breaks down everything you need to know about telehealth access to BED medications in 2025-2026, including what’s legal, what’s safe, and how to find quality care online.

Understanding Binge Eating Disorder and Medication Treatment

Binge eating disorder is the most common eating disorder in the United States, affecting millions of adults. It’s characterized by recurrent episodes of eating large amounts of food in a short period (typically within two hours), accompanied by a sense of loss of control. Unlike bulimia, BED doesn’t involve compensatory behaviors like purging or excessive exercise.

According to DSM-5 criteria, a BED diagnosis requires:

• Recurrent binge eating episodes (eating an unusually large amount with loss of control)
• Episodes occurring at least once weekly for three months
• Marked distress about binge eating
• Absence of regular compensatory behaviors

Common Medications Used for BED

While only one medication (Vyvanse/lisdexamfetamine) has FDA approval specifically for moderate-to-severe BED, it’s a controlled stimulant with stricter telehealth limitations. Instead, many clinicians prescribe non-controlled medications off-label with good clinical evidence:

Topamax (Topiramate): Originally approved for seizures and migraines, topiramate has shown promise in reducing binge frequency and supporting weight management in BED patients. Clinical studies suggest it may help with impulse control related to eating behaviors.

Wellbutrin (Bupropion): This antidepressant, also used for smoking cessation, can help reduce binge episodes in some patients, particularly those with co-occurring depression or emotional eating patterns.

Both medications are non-controlled substances, which is crucial for telehealth access—they’re not subject to the strict federal prescribing rules that apply to stimulants or opioids.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

The Legal Landscape: Federal Telehealth Prescribing Rules

Understanding the regulatory framework helps clarify what’s possible through online care.

Federal Rules Don’t Restrict Non-Controlled Medications

Here’s the key point many patients miss: The Ryan Haight Act, which requires an in-person medical evaluation before prescribing controlled substances via telemedicine, has never applied to non-controlled medications like Topamax or Wellbutrin.

During the COVID-19 pandemic, emergency rules allowed even controlled substances (like ADHD medications) to be prescribed via telehealth without an initial in-person visit. Those temporary flexibilities have been extended multiple times—most recently through December 31, 2026—but they only affect controlled substances.

For BED medications like topiramate and bupropion, there’s no federal barrier to telehealth prescribing. As long as your provider is licensed in your state and follows appropriate standards of care, they can evaluate and treat you entirely online.

What This Means for You

• No mandatory in-person visit at the federal level for these medications
• Telehealth evaluations can establish the patient-provider relationship needed for prescribing
• Providers can send prescriptions electronically to your local pharmacy
• Refills can typically be authorized for up to 90 days, with follow-up visits conducted via video

State-by-State Variations: What You Need to Know

While federal law permits telehealth prescribing of non-controlled medications, individual states have additional regulations. Most states have embraced telehealth permanently, but a few maintain specific requirements.

States with No In-Person Requirements

California, New York, Texas, Delaware, Florida, Michigan, Wisconsin, and South Carolina allow healthcare providers to prescribe non-controlled medications via telehealth without ever requiring an in-person visit, as long as the telehealth examination meets the same standard of care as an in-person evaluation.

California even explicitly allows asynchronous telehealth (questionnaire-based) evaluations if they’re clinically appropriate, though most BED treatment requires a real-time video consultation.

States Requiring Periodic In-Person Follow-Up

Alabama and Georgia have moderate restrictions:

• Alabama: If you have more than four telehealth visits for the same condition within 12 months, you must be seen in person within one year. This in-person visit can be with a collaborating provider, not necessarily your telehealth prescriber.

• Georgia: Requires an attempt at an annual in-person examination for ongoing telemedicine care, though initial evaluation can be done via telehealth if it’s clinically equivalent to in-person.

New Hampshire: Allows telehealth prescribing even for controlled substances, but requires an in-person follow-up exam at least every 12 months for ongoing controlled medication treatment. For non-controlled BED medications, this requirement is less strict, though annual in-person follow-up is considered best practice.

The Bottom Line on State Requirements

For the vast majority of states, you can initiate and continue BED medication treatment entirely through telehealth without in-person visits. Even in the few states with periodic in-person requirements, you can start treatment online—you’d only need an in-person visit if continuing long-term (usually after a year), and often this can be fulfilled by seeing any local healthcare provider for a basic check-up.

Who Can Prescribe BED Medications via Telehealth?

The provider type matters, and regulations vary significantly by state.

Physicians (MDs and DOs)

Medical doctors and doctors of osteopathy can prescribe these medications in all states via telehealth, assuming they’re licensed where you’re located.

Nurse Practitioners (NPs)

This is where state laws diverge significantly. As of 2025, 34 states plus DC grant Nurse Practitioners Full Practice Authority (FPA), meaning they can evaluate, diagnose, and prescribe medications independently without physician oversight.

States with NP Full Practice Authority (as of 2025) include:

• Recently added: Wisconsin, Michigan, Louisiana, Kansas (all added FPA in 2023-2025)
• Long-standing FPA states: New York, California, New Hampshire, Delaware, and many others

In FPA states, an NP can be your sole provider for BED treatment—no physician collaboration required.

States Requiring NP Collaboration include Texas, Florida, Georgia, and Alabama. In these states, NPs can still prescribe Topamax and Wellbutrin for BED, but they must work under a collaborative agreement with a physician. This is typically a behind-the-scenes administrative requirement—you may never interact with the collaborating physician, and it doesn’t affect your access to care.

Physician Assistants (PAs)

PAs can prescribe these non-controlled medications in all states, though they generally require a supervising or collaborating physician. The scope varies by state, but for non-controlled legend drugs, PA prescribing is widely permitted.

What About Prescription Monitoring Programs?

Many states require prescribers to check the state’s Prescription Drug Monitoring Program (PDMP) database before prescribing controlled substances. Since Topamax and Wellbutrin aren’t controlled, these mandatory PDMP checks typically don’t apply.

That said, responsible telehealth providers may still review your medication history as a safety precaution—for example, to ensure you’re not already taking another form of bupropion or a medication that could interact. This is good clinical practice, not a legal requirement.

Finding Quality Telehealth Care for BED

The expansion of telehealth has brought both opportunity and risk. High-profile cases—like the 2024 federal indictment of executives from a telehealth company for allegedly running an unsafe ‘pill mill’ for ADHD medications—have highlighted the importance of choosing reputable providers.

What to Look for in a Telehealth Provider

Comprehensive Evaluation: A legitimate provider will conduct a thorough initial assessment, typically 30+ minutes, asking detailed questions about:

• Your eating behaviors and patterns
• Mental health history (depression, anxiety, trauma)
• Medical history and current medications
• Previous treatments you’ve tried
• Your goals and concerns

Transparent Licensing: Providers must be licensed in your state. Reputable platforms verify this and clearly display provider credentials.

Multidisciplinary Approach: The gold standard for BED treatment combines medication with therapy (particularly cognitive-behavioral therapy or dialectical behavior therapy) and nutritional counseling. Be wary of services that push medication only without discussing other treatment options.

Clear Informed Consent: You should receive detailed information about:

• The off-label use of these medications for BED
• Potential side effects and contraindications
• Expected timeline for results
• Follow-up schedule
• When you might need in-person care

Appropriate Safety Screening: Providers should screen for conditions that would make these medications unsafe, such as:

• History of seizure disorders (contraindication for bupropion)
• History of anorexia or bulimia (bupropion carries a black-box warning due to seizure risk)
• Pregnancy or plans to become pregnant (topiramate can cause birth defects)
• Uncontrolled high blood pressure
• Recent or current use of MAO inhibitors

Red Flags to Avoid

• Promises of a prescription before proper evaluation
• Extremely short consultations (under 15 minutes)
• No discussion of therapy or lifestyle modifications
• Lack of clear follow-up plan
• Providers not licensed in your state
• Shipping medications directly rather than using a licensed pharmacy

Klarity Health’s Approach to BED Treatment

At Klarity Health, we take a comprehensive approach to binge eating disorder treatment through our telehealth platform. Our network of licensed providers includes physicians and nurse practitioners (in states where they have prescriptive authority) who specialize in eating disorders and mental health.

What sets Klarity apart:

• Provider Availability: Most patients can schedule an initial consultation within 24-48 hours, with evening and weekend appointments available
• Transparent Pricing: We clearly display costs upfront and accept both insurance and self-pay options
• Comprehensive Care: Our providers don’t just prescribe medication—they develop personalized treatment plans that may include therapy referrals and ongoing support
• Licensed Nationwide: Our providers are licensed in your state and follow all state-specific regulations
• Evidence-Based Treatment: We use medications supported by clinical research and follow established safety protocols

What to Expect: The Telehealth Treatment Process

Initial Consultation

Your first appointment will typically involve:

1. Identity and Location Verification: Providers are required to confirm who you are and where you’re located (to ensure proper licensing)

2. Comprehensive History: Expect detailed questions about your eating patterns, including:

• Frequency and duration of binge episodes
• Triggers and circumstances around binge eating
• Emotional state before, during, and after episodes
• Other eating disorder symptoms

1. Mental Health Screening: Assessment for co-occurring conditions like depression, anxiety, or trauma

2. Medical Review: Discussion of medical history, current medications, allergies, and contraindications

3. Treatment Planning: If appropriate, your provider will discuss medication options, including:

• How the medication works
• Expected benefits and timeline
• Potential side effects
• Starting dose and titration schedule
• Alternative options

1. Informed Consent: You’ll sign consent forms acknowledging the off-label use of medication and understanding the treatment plan

Medication Details

Topiramate (Topamax):

• Starting Dose: Usually 25-50mg daily, increased gradually
• Target Dose: Often 75-200mg daily for BED (lower than seizure treatment doses)
• Timeline: May take 4-8 weeks to see effects on binge frequency
• Common Side Effects: Tingling in hands/feet, altered taste (especially carbonated beverages), cognitive effects (‘word-finding difficulty’), decreased appetite
• Serious Considerations: Birth defect risk—requires effective contraception in women of childbearing potential; kidney stone risk; eye pressure issues
• Monitoring: Regular check-ins to assess side effects, cognitive function, and treatment response

Bupropion (Wellbutrin):

• Starting Dose: Typically 150mg daily of extended-release formulation
• Target Dose: May increase to 300mg daily
• Timeline: Effects on mood often appear within 2-4 weeks; binge reduction may take 4-8 weeks
• Common Side Effects: Insomnia, dry mouth, headache, increased energy/anxiety initially
• Black Box Warning: Increased risk of suicidal thoughts in people under 25, especially in the first few months—requires close monitoring
• Contraindications: Cannot be used if you have current or past bulimia or anorexia (seizure risk), seizure disorders, or are abruptly stopping alcohol/benzodiazepines
• Monitoring: Regular mood checks, blood pressure monitoring if indicated

Follow-Up Care

Typical Schedule:

• 2-week check-in: Assess initial tolerance, adjust dose if needed
• Monthly visits for the first 3 months: Monitor progress, side effects, and safety
• Bimonthly or quarterly visits thereafter: Continue monitoring and adjust treatment as needed
• Annual comprehensive review: Some states require this; good practice everywhere

What’s Covered in Follow-Ups:

• Frequency and severity of binge episodes
• Side effects and tolerability
• Weight and metabolic parameters
• Mood and overall well-being
• Medication adherence
• Need for dose adjustment
• Integration with therapy or other treatments

Prescription and Refills

Your provider will send prescriptions electronically to your chosen pharmacy. For these non-controlled medications, prescriptions can often include refills (up to 6-12 months depending on state law), though you’ll still need regular follow-up appointments.

Supply Duration: Typically 30-90 days per fill, with multiple refills authorized

Who Should NOT Use Telehealth for BED Medication?

While telehealth works well for many people, certain situations require in-person evaluation:

Absolute Contraindications for These Medications

For Bupropion (Wellbutrin):

• Current or past anorexia nervosa or bulimia nervosa
• Seizure disorder or conditions that increase seizure risk
• Abrupt discontinuation of alcohol or sedatives (undergoing withdrawal)
• Current use of MAO inhibitors or within 14 days of stopping them
• Concurrent use of another bupropion product

For Topiramate (Topamax):

• Pregnancy or planning pregnancy without effective contraception
• Metabolic acidosis
• Allergy to sulfa drugs (relative contraindication)

Clinical Situations Requiring In-Person Care

• Severe Medical Instability: Uncontrolled diabetes, severe cardiac disease, or other conditions requiring hands-on examination
• Acute Safety Concerns: Active suicidal ideation, severe self-harm, or acute medical crisis
• Complex Medical Needs: Multiple serious health conditions requiring coordination between specialists
• Need for Physical Examination: Situations where a provider needs to perform a physical exam (checking reflexes, abdominal examination, etc.)
• Previous Adverse Reactions: If you’ve had serious reactions to these medications before

When Controlled Substances Might Be Needed

The only FDA-approved medication specifically for BED is Vyvanse (lisdexamfetamine), a Schedule II controlled stimulant. Due to tighter telehealth restrictions on controlled substances and concerns about misuse, most telehealth platforms don’t prescribe stimulants for BED.

If your symptoms are severe and haven’t responded to non-controlled options, your telehealth provider may refer you to an in-person specialist who can evaluate you for Vyvanse or other controlled medications.

Safety, Quality, and Regulatory Oversight

Recent Regulatory Actions

The telehealth industry has faced increased scrutiny following concerning practices at some online providers. In 2024, federal prosecutors indicted executives of a major telehealth company for allegedly prescribing ADHD stimulants unsafely—including to patients with substance abuse histories and without proper evaluations.

What this means for patients: Regulatory agencies (DEA, state medical boards, FTC) are actively monitoring telehealth prescribing practices. This is ultimately good news—it weeds out bad actors while legitimate providers implement stronger safeguards.

How States Are Responding

Many states have clarified or strengthened telehealth standards:

• New York (May 2025): Implemented rules requiring in-person exams before prescribing controlled substances once federal waivers expire, while maintaining flexibility for non-controlled medications
• New Hampshire (August 2025): Passed legislation explicitly allowing telehealth prescribing with clear annual follow-up requirements
• California (2025): Redefined ‘good faith examination’ to explicitly include asynchronous telehealth when clinically appropriate

Best Practices for Patients

Before Starting Treatment:

• Research the telehealth provider—check reviews, licensing, and accreditation
• Verify your provider is licensed in your state
• Ask about their experience treating eating disorders
• Understand the total cost (consultation, medication, follow-ups)
• Review privacy policies and how your data is protected

During Treatment:

• Be completely honest about your symptoms and history
• Report side effects promptly
• Attend all scheduled follow-ups
• Don’t adjust doses without consulting your provider
• Use only one pharmacy to avoid dangerous drug interactions

Red Flags During Treatment:

• Provider becomes difficult to reach
• Prescription refills without any check-in
• Pressure to increase doses rapidly
• Dismissal of your concerns about side effects

Insurance Coverage and Costs

Insurance Coverage for Telehealth BED Treatment

Most insurance plans now cover telehealth visits at the same rate as in-person visits, thanks to policy changes that became permanent after the pandemic. However, coverage specifics vary:

What’s Typically Covered:

• Initial psychiatric evaluation via telehealth
• Follow-up medication management visits
• Some plans cover therapy sessions (individual CBT/DBT)

Medication Coverage:

• Topiramate (generic): Usually covered with low copays ($4-$30/month)
• Bupropion (generic): Typically covered ($4-$40/month)
• Brand-name versions: May require prior authorization or step therapy

Check with Your Plan: Contact your insurance to verify:

• Telehealth coverage policies
• Mental health/psychiatric visit copays
• Medication formulary and restrictions
• Need for prior authorization
• In-network vs. out-of-network coverage

Self-Pay Options

If you’re paying out of pocket, costs typically include:

Initial Consultation: $150-$300Follow-Up Visits: $75-$150 (typically 15-30 minutes)Medications (without insurance):

• Generic topiramate: $15-$40/month
• Generic bupropion: $10-$30/month

Many telehealth platforms, including Klarity Health, offer transparent self-pay pricing and accept both insurance and cash payment, giving you flexibility based on your situation.

Complementary Treatments and Holistic Care

While medication can be helpful for many people with BED, the most effective approach is usually multimodal:

Evidence-Based Psychotherapy

Cognitive Behavioral Therapy (CBT): The gold standard for BED treatment, focusing on:

• Identifying triggers for binge eating
• Developing coping strategies
• Challenging distorted thoughts about food and body image
• Establishing regular eating patterns

Dialectical Behavior Therapy (DBT): Particularly helpful if emotional dysregulation drives binge eating, teaching:

• Distress tolerance skills
• Emotion regulation
• Mindfulness around eating
• Interpersonal effectiveness

Nutritional Counseling

Working with a registered dietitian who specializes in eating disorders can help:

• Establish regular, balanced meals
• Reduce food restriction (which often triggers binges)
• Address nutritional deficiencies
• Develop a healthy relationship with food

Lifestyle Modifications

• Sleep Hygiene: Poor sleep is linked to increased binge eating
• Stress Management: Meditation, yoga, or other stress-reduction techniques
• Physical Activity: Gentle, joyful movement (not compensatory exercise)
• Social Support: Support groups or peer connections

Many telehealth platforms can connect you with therapists and dietitians in addition to medication management, creating a comprehensive treatment plan.

Looking Ahead: The Future of Telehealth for BED

Regulatory Trends

The DEA is expected to finalize permanent telehealth rules for controlled substances by the end of 2026. While this won’t directly affect non-controlled BED medications, it will shape the overall telehealth landscape.

State legislatures continue to expand nurse practitioner independence (improving access in rural areas) and refine telehealth standards. The trend is toward more access, with stronger safety guardrails—a positive development for patients.

Technology Advancements

Emerging technologies may enhance BED treatment:

• AI-assisted screening: Better identification of BED symptoms during intake
• Remote monitoring: Apps that help track binge episodes and mood patterns
• Virtual reality therapy: Experimental treatments for eating disorders
• Asynchronous care: Secure messaging for check-ins between visits

Research Developments

Ongoing clinical trials are investigating:

• New medications for BED (including glucagon-like peptide-1 receptor agonists)
• Optimal medication combinations
• Biomarkers to predict medication response
• Digital therapeutics (app-based treatments)

As evidence evolves, telehealth providers will integrate new options into treatment protocols.

Taking the Next Step

If you’re struggling with binge eating disorder, telehealth offers a accessible, evidence-based path to treatment. Here’s how to get started:

1. Self-Assessment: Honestly evaluate whether your eating patterns meet BED criteria (recurrent binges, loss of control, distress, weekly for 3+ months)

2. Medical Review: Consider any medical conditions or medications that might affect treatment options

3. Research Providers: Look for licensed telehealth services with:

• Eating disorder expertise
• Clear pricing and policies
• Good patient reviews
• Comprehensive approach (not just medication)

1. Schedule a Consultation: Most platforms make booking easy—often within 24-48 hours

2. Prepare for Your Appointment:

• List all current medications and supplements
• Document your binge eating patterns (frequency, triggers, what you eat)
• Write down questions or concerns
• Have your pharmacy information ready

1. Commit to the Process: Medication can help, but recovery from BED is a journey. Plan for:

• Regular follow-ups
• Possible side effects adjustment period
• Integration with therapy
• Patience (results take weeks, not days)

Get Started with Klarity Health Today

At Klarity Health, we make it simple to connect with experienced providers who understand binge eating disorder. Our platform offers:

✓ Fast Access: Appointments available within 24-48 hours
✓ Licensed Providers: MDs and NPs (where permitted) licensed in your state
✓ Flexible Scheduling: Evening and weekend appointments
✓ Transparent Costs: Clear pricing with both insurance and self-pay options
✓ Comprehensive Care: Treatment plans tailored to your unique needs

Whether you’re seeking an initial evaluation or looking for ongoing medication management, our providers are here to help you on your journey to recovery from binge eating disorder.

Take the first step today: Visit our website to learn more about BED treatment options and schedule your confidential consultation. You don’t have to struggle alone—effective, accessible help is just a click away.

Frequently Asked Questions

Is telehealth treatment for BED as effective as in-person care?
Research shows that telehealth can be equally effective for many mental health conditions when conducted properly. For BED medication management, studies indicate comparable outcomes in terms of reduced binge frequency and improved quality of life.

How long does BED medication treatment typically last?
Treatment duration varies by individual. Some people benefit from 6-12 months of medication combined with therapy, while others may need longer-term treatment. Your provider will work with you to determine the optimal duration.

Can I get therapy and medication through the same telehealth platform?
Many platforms, including Klarity Health, offer both psychiatric medication management and therapy services, allowing coordinated care with providers who communicate about your treatment.

What if the first medication doesn’t work for me?
Not everyone responds to the same medication. If topiramate or bupropion doesn’t help after an adequate trial (typically 8-12 weeks at therapeutic doses), your provider can try the other option, adjust the dose, or consider combination therapy.

Will my employer or insurance company know about my BED treatment?
Your diagnosis and treatment are protected health information under HIPAA. Insurance claims will show that you received psychiatric/mental health services, but specific diagnosis details are confidential. Many people choose self-pay options for additional privacy.

Can I stop medication once my binge eating improves?
Never stop these medications abruptly, especially topiramate (seizure risk). Work with your provider to gradually taper if discontinuing. Many people benefit from transitioning to therapy-only maintenance after medication has helped establish healthier patterns.

Research Currency Statement

Verified as of: January 4, 2026

• DEA Rules Status: COVID-19 telehealth prescribing flexibilities remain in effect through December 31, 2026 (fourth extension). No federal in-person requirement exists for non-controlled medications—these were never subject to the Ryan Haight Act restrictions on telemedicine. Controlled substance telehealth rules are temporary and extended through 2026 pending a permanent DEA rule.

• States Verified: Researched 10+ key states (AL, CA, DE, FL, GA, NH, NY, TX, MI, WI, etc.) with latest information as of late 2025. State board websites and 2025 legislative updates were checked where available.

• Sources newer than 2024: 80%+ of sources are from 2025 (many late-2025) or updated to 2025. Older sources (2024) were used only when confirmed still accurate by newer references.

• ⚠️ Flagged for follow-up: Alabama and South Carolina NP scope changes (legislation was discussed in 2025 but final status unclear—assume no full independence yet pending confirmation). Monitor DEA’s pending final rule on telehealth prescribing (expected by end of 2026). Verify any temporary state waivers for expiration/extension beyond 2025.

References

1. U.S. Department of Health and Human Services. (2026, January). ‘DEA Extends Telemedicine Prescribing Flexibilities Through December 2026.’ HHS Press Room. https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html

2. Sheppard Mullin Richter & Hampton LLP. (2025, August). ‘Telehealth and In-Person Visits: Tracking Federal and State Updates to Pandemic-Era Telehealth Exceptions.’ Healthcare Law Blog. https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/

3. Center for Connected Health Policy. (2025, November-December). ‘State Telehealth Laws and Reimbursement Policies: Online Prescribing.’ CCHP State Policy Database. https://www.cchpca.org/topic/online-prescribing/

4. Health Jobs Nationwide. (2025, October). ‘State-by-State Guide: Expanding Roles for PAs and NPs (Updated 2025).’ https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/

5. DailyMed, National Library of Medicine. (2024). ‘Bupropion Hydrochloride Extended-Release Tablets – FDA Prescribing Information.’ https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=1b69c253-4740-44b0-be63-6c20834540b6

Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for diagnosis and treatment of binge eating disorder or any medical condition. Medication information is current as of the publication date but may change. State telehealth regulations are subject to change; verify current rules in your state.

Source:

• https://www.hhs.gov/press-room/dea-telemedicine-extension-2026.html#:~:text=patients%20to%20receive%20prescriptions%20for,while%20permanent%20rules%20are%20finalized
• https://www.sheppardhealthlaw.com/2025/08/articles/telehealth/telehealth-and-in-person-visits-tracking-federal-and-state-updates-to-pandemic-era-telehealth-exceptions/#:~:text=extended%20telemedicine%20prescribing%20waivers%20through,prescribing
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=Full%20practice%20authority%20legislation%20reached,12
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=coordination%20with%20the%20U,prescribing
• https://telehealth.hhs.gov/providers/telehealth-policy/prescribing-controlled-substances-via-telehealth#:~:text=The%20Drug%20Enforcement%20Administration%20,through%20December%2031%2C%202025
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era?amp=#:~:text=Prior%20to%20the%202024%20waiver,access%2C%20and%20diversion%20control%20measures
• https://www.cchpca.org/topic/online-prescribing/#:~:text=If%20a%20physician%20or%20practice,resolution%2C%20the%20physician%20shall%20either
• https://www.cchpca.org/topic/online-prescribing/#:~:text=Prescribing%2C%20dispensing%2C%20or%20furnishing%20dangerous,the%20appropriate%20standard%20of%20care
• https://www.cchpca.org/topic/online-prescribing/#:~:text=constitutes%20unprofessional%20conduct,the%20appropriate%20standard%20of%20care
• https://blog.healthjobsnationwide.com/state-by-state-guide-expanding-roles-for-pas-and-nps-updated-2025/#:~:text=California%20leads%20the%20most%20important,12